XML 96 R49.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions (Schedule Of Pro Forma Consolidated Results) (Details) (Paladin Labs Inc. [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Paladin Labs Inc. [Member]
     
Business Acquisition, Equity Interests Issued or Issuable [Line Items]      
Revenue $ 783,249 $ 2,120,231 $ 2,390,957
Net (loss) income attributable to Endo International plc $ 46,687 $ (678,399) $ 95,082
Basic net (loss) income per share (in dollars per share) $ 0.41 $ (4.69) $ 0.84
Diluted net (loss) income per share (in dollars per share) $ 0.39 $ (4.69) $ 0.81